Document Detail

Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
MedLine Citation:
PMID:  15698589     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Free radical induced renal damage leads to crystal retention and formation of large stones. However, the scenario behind uric acid (UA) stone formation is still a mystery, as uric acid, a risk factor of stone formation, seems to be a potent antioxidant that can protect cells from damage by reactive oxygen species. This study was intended to evaluate the role of uric acid in stone formers by assessing the oxidative stress status of the stone patients. METHODS: Determination of urinary stone forming risk factors and oxidative stress factors like plasma lipid peroxidation, protein carbonyls of stone formers and histopathological changes and uric acid deposition in stone patients kidney biopsy were studied. RESULTS: Increased concentrations of urinary uric acid and oxalate in both uric acid as well as calcium oxalate stone formers were observed, whereas calcium is increased in calcium stone formers and not in the uric acid stone patients. Inhibitors such as citrate and glycosaminoglycans (GAGs) were found to be significantly decreased in all the stone patients. Histopathological studies confirmed the deposition of crystals in the damaged tubules and De Galantha staining authenticates that the damage is caused due to uric acid crystals. Increased oxidative stress is dictated by the concentrations of lipid peroxidation and protein carbonyls in stone formers. Moreover, increased activities of urinary marker enzymes substantiate the tubular damage. CONCLUSION: We speculated that uric acid acts as a calculi forming salt rather than an antioxidant and it has no role in preventing oxidative stress pertaining to urolithiasis.
S Srinivasan; P Kalaiselvi; R Sakthivel; V Pragasam; V Muthu; P Varalakshmi
Related Documents :
2000819 - Milk- and soy-protein ingestion: acute effect on serum uric acid concentration.
6712409 - Urine uric acid and urine creatine ratio in acute renal failure.
372609 - Ticrynafen and hydrochlorothiazide. a double-blind study of antihypertensive properties...
6895439 - Hyperuricemia and gout: an update.
10596359 - Formulation development of allopurinol suppositories and injectables.
2330229 - Uric acid metabolism in children.
10341359 - The cannabinoid acids: nonpsychoactive derivatives with therapeutic potential.
3943899 - Isolation, purification, and partial characterization of a lipopolysaccharide from haem...
1657429 - Modifying effects of the naturally occurring antioxidants gamma-oryzanol, phytic acid, ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinica chimica acta; international journal of clinical chemistry     Volume:  353     ISSN:  0009-8981     ISO Abbreviation:  Clin. Chim. Acta     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-08     Completed Date:  2005-04-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1302422     Medline TA:  Clin Chim Acta     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  45-51     Citation Subset:  IM    
Department of Medical Biochemistry, Dr. A.L. Mudaliar Post Graduate Institute of Basic Medical Sciences, Taramani, University of Madras, Chennai 600 113, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcium Oxalate / metabolism*
Middle Aged
Occupational Diseases / blood*
Uric Acid / blood*
Urinary Calculi / blood,  etiology*
Reg. No./Substance:
25454-23-3/Calcium Oxalate; 69-93-2/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The use of plasma metanephrine to normetanephrine ratio to determine epinephrine poisoning.
Next Document:  Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-...